1. Sudhakar, Digumarthi V S, Phanindranath, Regur, Jaishankar, Shveta, Gopalakrishnan, Jay, Thangaraj, Kumarasamy. . Exome sequencing and functional analyses revealed CETN1 variants leads to impaired cell division and male fertility. In Human molecular genetics, 32, 533-542. doi:10.1093/hmg/ddac216. https://pubmed.ncbi.nlm.nih.gov/36048845/
2. Zhang, Wen, Cao, Xiangrong, Shen, Quan, Hua, Xiuguo, Zhang, Xiran. 2008. Isolation and characterization of the Cetn1 gene from tufted deer (Elaphodus cephalophus). In Biochemical genetics, 46, 652-62. doi:10.1007/s10528-008-9179-1. https://pubmed.ncbi.nlm.nih.gov/18751886/
3. Andres, Sarah A, Bickett, Katie E, Alatoum, Mohammad A, Brock, Guy N, Wittliff, James L. 2015. Interaction between smoking history and gene expression levels impacts survival of breast cancer patients. In Breast cancer research and treatment, 152, 545-56. doi:10.1007/s10549-015-3507-z. https://pubmed.ncbi.nlm.nih.gov/26202054/
4. Kim, John J, Rajagopalan, Krithika, Hussain, Basil, Kulkarni, Prakash, Mooney, Steven M. 2013. CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers. In Biomarker research, 1, 22. doi:10.1186/2050-7771-1-22. https://pubmed.ncbi.nlm.nih.gov/24252580/
5. Shuangta, Xu, Yali, He, Zhengrong, Zheng, Yinghui, Liang, Jianhua, Xu. . Knockdown of CETN1 inhibits breast cancer cells proliferation. In Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 19, 656-61. doi:. https://pubmed.ncbi.nlm.nih.gov/25261648/
6. Jiao, Rubin, Allen, Kevin J H, Malo, Mackenzie E, Bryan, Ruth A, Dadachova, Ekaterina. 2019. Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer. In Cancer medicine, 8, 5289-5300. doi:10.1002/cam4.2379. https://pubmed.ncbi.nlm.nih.gov/31309741/